Sinopharm Group Co Stock Z Score
SHTDFDelisted Stock | USD 2.70 0.00 0.00% |
Sinopharm |
Sinopharm Group Co Company Z Score Analysis
Sinopharm Group's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Sinopharm Group Z Score | 1.6 |
Most of Sinopharm Group's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sinopharm Group Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, Sinopharm Group Co has a Z Score of 1.6. This is 76.3% lower than that of the Healthcare sector and 71.27% lower than that of the Medical Distribution industry. The z score for all United States stocks is 81.65% higher than that of the company.
Sinopharm Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sinopharm Group's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Sinopharm Group could also be used in its relative valuation, which is a method of valuing Sinopharm Group by comparing valuation metrics of similar companies.Sinopharm Group is currently under evaluation in z score category among its peers.
Sinopharm Fundamentals
Return On Equity | 0.13 | |||
Return On Asset | 0.0364 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.04 % | |||
Current Valuation | 16.78 B | |||
Shares Outstanding | 1.34 B | |||
Shares Owned By Insiders | 0.01 % | |||
Shares Owned By Institutions | 51.07 % | |||
Price To Earning | 5.67 X | |||
Price To Book | 0.88 X | |||
Price To Sales | 0.01 X | |||
Revenue | 521.05 B | |||
Gross Profit | 44.05 B | |||
EBITDA | 20.76 B | |||
Net Income | 7.76 B | |||
Cash And Equivalents | 32.15 B | |||
Cash Per Share | 10.30 X | |||
Total Debt | 8.42 B | |||
Debt To Equity | 0.89 % | |||
Current Ratio | 1.31 X | |||
Book Value Per Share | 21.01 X | |||
Cash Flow From Operations | 9.31 B | |||
Earnings Per Share | 0.37 X | |||
Price To Earnings To Growth | 49.02 X | |||
Number Of Employees | 113.23 K | |||
Beta | 0.72 | |||
Market Capitalization | 8.94 B | |||
Total Asset | 335.41 B | |||
Retained Earnings | 11.43 B | |||
Working Capital | 32.26 B | |||
Current Asset | 130.51 B | |||
Current Liabilities | 98.25 B | |||
Z Score | 1.6 | |||
Annual Yield | 0.05 % | |||
Five Year Return | 3.09 % | |||
Net Asset | 335.41 B | |||
Last Dividend Paid | 0.75 |
About Sinopharm Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sinopharm Group Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sinopharm Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sinopharm Group Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Sinopharm Pink Sheet
If you are still planning to invest in Sinopharm Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sinopharm Group's history and understand the potential risks before investing.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |